• Product Pipeline
  • Immuno-Inflammatory
  • Pain
  • Topical Dermatology
  • Metabolic
  • Clinical Trials
  • Research Programs

Products Overview

CombinatoRx develops combination drug candidates in response to the understanding that many diseases affect the body through multiple biological pathways. The activity of a therapeutic compound against one pathway can be insufficiently effective because biological systems often compensate by using a secondary pathway. By targeting multiple pathways, our combination drug candidates create synergistic therapeutic effects, which could result in improved treatment for many diseases.

CRx-102 CRx-191 CRx-197 CRx-401 CRx-139 CRx-170
CombinatoRx Clinical Trials